<DOC>
	<DOCNO>NCT01727791</DOCNO>
	<brief_summary>This pharmacokinetic study determine safety tolerability pregabalin healthy lactate woman . The objective determine whether pregabalin secrete breast milk , characterize pregabalin pharmacokinetics breast milk . Other objective estimate potential infant exposure pregabalin administer lactating woman characterize safety tolerability pregabalin lactate woman .</brief_summary>
	<brief_title>A Study Of Pregabalin ( Lyrica ) Drug Levels In Urine , Plasma And Breast Milk Of Healthy Lactating Women</brief_title>
	<detailed_description>Post approval commitment FDA</detailed_description>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Healthy lactating female age 18 45 year ( inclusive ) actively breastfeed express breast milk least 12 week post partum . Subjects must willing temporarily discontinue breast feeding infant Day 1 even dose 42 hour last dose History significant adverse reaction pregabalin gabapentin . Subjects pregnant unwilling unable comply Lifestyle guideline present protocol study period followup visit . Subjects evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric ( include post natal depression ) , neurologic allergic disease ( include drug allergy , exclude untreated asymptomatic , seasonal allergy time dose ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>pharmacokinetic</keyword>
	<keyword>pregabalin</keyword>
	<keyword>lactation</keyword>
</DOC>